Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christina F. Lusi"'
Autor:
Ravi Bharadwaj, Christina F. Lusi, Siavash Mashayekh, Abhinit Nagar, Malireddi Subbarao, Griffin I. Kane, Kimberly Wodzanowski, Ashley Brown, Kendi Okuda, Amanda Monahan, Donggi Paik, Anubhab Nandy, Madison Anonick, William E. Goldman, Thirumala-Devi Kanneganti, Megan H. Orzalli, Catherine Leimkuhler Grimes, Prabhani U. Atukorale, Neal Silverman
SummaryCytosolic innate immune sensing is critical for protecting barrier tissues. NOD1 and NOD2 are cytosolic sensors of small peptidoglycan fragments (muropeptides) derived from the bacterial cell wall. These muropeptides enter cells, especially ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f06a72355307ae7569241110405574d
https://doi.org/10.1101/2022.09.29.509906
https://doi.org/10.1101/2022.09.29.509906
Autor:
Ravi Bharadwaj, Christina F. Lusi, Siavash Mashayekh, Abhinit Nagar, Malireddi Subbarao, Griffin I. Kane, Kimberly A. Wodzanowski, Ashley R. Brown, Kendi Okuda, Amanda Monahan, Donggi Paik, Anubhab Nandy, Madison V. Anonick, William E. Goldman, Thirumala-Devi Kanneganti, Megan H. Orzalli, Catherine Leimkuhler Grimes, Prabhani U. Atukorale, Neal Silverman
Publikováno v:
Immunity. 56:998-1012.e8
Autor:
Prabhani U. Atukorale, Taylor J. Moon, Alexandr R. Bokatch, Christina F. Lusi, Jackson T. Routhier, Victoria J. Deng, Efstathios Karathanasis
Publikováno v:
Nanoscale
Lethal cancer is characterized by drug-resistant relapse and metastasis. Here, we evaluate the efficacy of a neoadjuvant therapeutic strategy prior to surgery that combines the immune checkpoint inhibitor anti-PD1 with a powerful immunostimulatory na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e009dae35360a4f72d75c82b4129154
https://europepmc.org/articles/PMC8795493/
https://europepmc.org/articles/PMC8795493/